By Editor , 1 October 2026
MP Materials CEO Litinsky Tops 2026 Mining Pay Rankings at $28M

Toronto – October 01, 2026 -- MP Materials Founder, Chairman and CEO James Litinsky recorded fiscal 2025 total compensation of US$28.0 million (C$39.2 million), the highest figure in Bedford Group/TRANSEARCH's 2026 mining compensation rankings.

By Editor , 1 October 2026
Equinix Sets Oct. 28 Call to Report Q3 2026 Results

Redwood City, Calif. – October 01, 2026 -- Equinix, Inc. (Nasdaq: EQIX) will report third-quarter 2026 results for the period ended September 30, 2026, during a conference call scheduled for Wednesday, October 28, 2026, at 5:30 p.m. ET.

Equinix confirms October 28 call time and dial-in details

The call will take place at 2:30 p.m. PT. Participants can dial 1-517-308-9482 domestically and internationally using passcode EQIX, with a simultaneous live webcast available on the company's Investor Relations site.

By Editor , 1 October 2026
Wayfair to Report Q3 2026 Earnings on November 4

Boston -- October 1, 2026 -- Wayfair Inc. (NYSE: W) will release third-quarter 2026 financial results before market open on November 4, 2026.

Wayfair schedules Q3 earnings call for November 4 at 8 a.m. ET

The company confirmed the quarter ended September 30, 2026, with a conference call set to review results the same morning the figures are published.

By Editor , 1 October 2026
Solstice Advanced Materials to Report Q3 Results Nov. 4

Morris Plains, N.J. – – October 01, 2026 -- Solstice Advanced Materials (NASDAQ: SOLS) will release its third-quarter 2026 financial results before market open on November 4, 2026, the specialty materials company confirmed.

By Editor , 1 October 2026
Sharon AI Secures $356M GPU-Backed Debt Facility at 9.95%

New York – October 01, 2026 -- Sharon AI Holdings Inc. (NASDAQ: SHAZ) has closed its inaugural US$356 million committed senior secured, GPU-backed SPV debt facility, priced at a fixed rate of 9.95% excluding fees.

By Editor , 1 October 2026
Lutris Pharma's LUT014 Gel Hits 71.8% Success Rate in Phase 2 Rash Trial

Tel Aviv, Israel – October 01, 2026 -- Lutris Pharma reported that its topical B-Raf inhibitor LUT014 achieved Treatment Success in 71.8% of patients with EGFR inhibitor-induced acneiform rash, compared with 38.5% on placebo (p=0.003), in updated Phase 2 data presented at the 35th EADV Congress in Vienna.

By Editor , 1 October 2026

Pensacola, Fla. – October 01, 2026 -- Baptist Health Care and PAM Health have restructured their joint venture, adding 40 acute care beds at Baptist Hospital and building a freestanding 60-bed inpatient rehabilitation hospital at Baptist Medical Park – Nine Mile, pushing Baptist Hospital's total bed count from 279 to 319.

By Editor , 1 October 2026
Mayfair Gold Secures C$310M Macquarie Package for Fenn-Gib Mine

Toronto – October 01, 2026 -- Mayfair Gold Corp. (TSXV: MFG) (NYSE American: MINE) has signed a subscription agreement for a C$10 million strategic equity investment from Macquarie Bank Limited and a non-binding term sheet for a proposed C$300 million project finance facility, bringing the total financing package for its Fenn-Gib Gold Project to up to C$310 million.

By Editor , 1 October 2026
Armadin Raises $255.5M Series B, Valuation Tops $2.5B

Palo Alto, Calif. -- October 1, 2026 -- Armadin, an AI-native cybersecurity company, has raised $255.5 million in a Series B round that pushes its valuation above $2.5 billion just seven months after launching from stealth. The round was co-led by Andreessen Horowitz (a16z) and Accel, with new investors Bain Capital Ventures and Redpoint joining. Existing backers 8VC, Ballistic Ventures, Google Ventures, In-Q-Tel, Kleiner Perkins, and Menlo Ventures also returned, lifting Armadin's total funding to $445 million.